Ambet, Alwina A.
HRN: 25-09-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2024
CO-AMOXICLAV 625MG (TAB)
05/27/2024
06/03/2024
PO
625mg
BID X 7 Days
S/P NSVD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes